[Anticoagulants and antithrombotics in rapidly progressive glomerulopnehritis in children].
D000925:Anticoagulants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects; D004176:Dipyridamole / Q000009:adverse effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000188:drug therapy*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D008297:Male; D011241:Prednisone / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D004176:Dipyridamole; D003520:Cyclophosphamide; D006493:Heparin; D011241:Prednisone
Anticoagulantes y antitrombóticos en la glomerulonefritis rápidamente progresiva del niño